Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient
AbstractThe purpose of the article Pyoderma gangrenosum (PG) is an ulcerating neutrophilic dermatosis with an incidence of 3-10 patients per million. PG equally affects patients of both sexes and of any age. Of these patients, 50-75% are associated with auto-immune disease. The lower extremities are...
Saved in:
Main Authors: | Na Wang (Author), Changping Yu (Author), Weiwei Wang (Author), Qing Yang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
by: Lindsey J. Wanberg, et al.
Published: (2024) -
Pyoderma Gangrenosum
by: Krishnan S G S, et al.
Published: (1997) -
Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review
by: Anna Gawdzik, et al.
Published: (2020) -
A case of vegetative pyoderma gangrenosum
by: Yan Jin, et al.
Published: (2015) -
Spesolimab use in treatment of pyoderma gangrenosum
by: Sophie H. Guénin, MSc, et al.
Published: (2023)